Bayer AG NA (BAYGn)

Xetra
Currency in EUR
21.03
+0.08(+0.38%)
Closed·
BAYGn Scorecard
Full Analysis
High shareholder yield
Fair Value
Day's Range
20.7121.13
52 wk Range
18.3831.03
Key Statistics
Edit
Bid/Ask
21.03 / 21.03
Prev. Close
20.96
Open
21.12
Day's Range
20.71-21.13
52 wk Range
18.38-31.03
Volume
2.72M
Average Volume (3m)
4.24M
1-Year Change
-20.11%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BAYGn Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
27.51
Upside
+30.79%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Bayer AG NA Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention products, digestive health products, allergy products, and cold and cough products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Employees
90587
Market
Germany

Compare BAYGn to Peers and Sector

Metrics to compare
BAYGn
Peers
Sector
Relationship
P/E Ratio
−8.1x17.5x−0.5x
PEG Ratio
−0.620.050.00
Price/Book
0.6x4.0x2.6x
Price / LTM Sales
0.4x2.5x2.9x
Upside (Analyst Target)
26.0%61.8%66.3%
Fair Value Upside
Unlock27.7%10.2%Unlock

Analyst Ratings

5 Buy
15 Hold
0 Sell
Ratings:
20 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 27.51
(+30.79% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -2.60%
Dividend Yield
0.52%
Industry Median 1.51%
Annualised payout
0.11
Paid annually
5-Years Growth
-47.66%
Growth Streak

Earnings

Latest Release
Mar 05, 2025
EPS / Forecast
1.05 / 0.99
Revenue / Forecast
11.73B / 11.32B
EPS Revisions
Last 90 days

FAQ

What Is the Bayer (BAYGn) Stock Price Today?

The Bayer stock price today is 21.03

What Stock Exchange Does Bayer Trade On?

Bayer is listed and trades on the Xetra stock exchange.

What Is the Stock Symbol for Bayer?

The stock symbol for Bayer is "BAYGn."

Does Bayer Pay Dividends? What’s The Current Dividend Yield?

The Bayer AG NA dividend yield is 0.52%.

What Is the Bayer Market Cap?

As of today, Bayer market cap is 20.66B.

What is Bayer Earnings Per Share?

The Bayer EPS is -2.60.

What Is the Next Bayer Earnings Date?

Bayer will release its next earnings report on 12 May 2025.

From a Technical Analysis Perspective, Is BAYGn a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.